European Journal of Clinical Pharmacology

, Volume 35, Issue 5, pp 555–562 | Cite as

Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects

  • P. Harper
  • C. -E. Elwin
  • G. Cederblad
Originals

Summary

The pharmacokinetics of single intravenous and oral doses of L-carnitine 2 g and 6 g has been investigated in 6 healthy subjects on a low carnitine diet.

Carnitine was more rapidly eliminated from plasma after the higher dose. Comparing the 2-g and 6-g doses, the t1/2β of the elimination phase (β) was 6.5 h vs 3.9 h, the elimination constant was 0.40 vs 0.50 h−1 and the plasma carnitine clearance was 5.4 vs 6.11 × h−1 (p<0.025), thus showing dose-related elimination.

Saturable kinetics was not found in the range of doses given. The apparent volumes of distribution after the two doses were not significantly different and they were of the same order as the total body water. Urinary recoveries after the 2-g and 6-g doses were 70% and 82% during the first 24 h, respectively.

Following the two oral dosing, there was no significant difference in AUCs of plasma carnitine. Urinary recoveries were 8% and 4% for the 2-g and 6-g doses during the first 24 h. The oral bioavailability of the 2-g dose was 16% and of the 6 h dose 5%. The results suggest that the mucosal absorption of carnitine is already saturated at the 2-g dose.

Key words

L-carnitine pharmacokinetics intravenous — oral doses bioavailability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bremer J (1983) Carnitine — metabolism and functions. Physiol Rev 63: 1420–1480Google Scholar
  2. 2.
    Rebouche CJ, Engel AG (1984) Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes: Evidence for alterations in tissue carnitine transport. J Clin Invest 73: 857–867Google Scholar
  3. 3.
    Bieber LL, Emaus R, Valkner K, Farrel S (1982) Possible functions of short-chain and medium-chain carnitine acyltransferases. Fed Proc 41: 2858–2862Google Scholar
  4. 4.
    Engel AG, Rebouche CJ (1984) Carnitine metabolism and inborn errors. J Inher Metab Dis 1 [Suppl]: 38–43Google Scholar
  5. 5.
    Welling PG, Thomsen JH, Shug AL, Tse FLS (1979) Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine. Int J Clin Pharmacol Biopharm 70: 56–60Google Scholar
  6. 6.
    Cederblad G (1984) Fat metabolism following an intravenous bolus dose of a fat emulsion and carnitine. Clin Physiol 4: 159–168Google Scholar
  7. 7.
    Bach AC, Schirardin H, Sihr M-O, Storck D (1983) Free and total carnitine in human serum after oral ingestion of L-carnitine. Diabetes Metabolism 9: 121–124Google Scholar
  8. 8.
    Frohlich J, Seccombe DW, Hahn P, Dodek P, Hynie I (1978) Effect of fasting on free and esterified carnitine levels in human serum and urine: Correlation with serum levels of free fatty acids and β-hydroxybutyrate. Metabolism 27: 555–561Google Scholar
  9. 9.
    Gross CJ, Henderson LM (1984) Absorption of D- and L-carnitine by the intestine and kidney tubule in the rat. Biochim Biophys Acta 772: 209–219Google Scholar
  10. 10.
    Rudman D, Sewell CW, Ansley JD (1977) Deficiency of carnitine in cachectic cirrhotic patients. J Clin Invest 60: 716–723Google Scholar
  11. 11.
    Naftalin L, Mitchell LR (1958) A new urine preservative. Clin Chim Acta 3: 197–199Google Scholar
  12. 12.
    Cederblad G, Lindstedt (1972) A method for the determination of carnitine in the picomole range. Clin Chim Acta 37: 235–243Google Scholar
  13. 13.
    Cederblad G, Finnström O, Mårtensson J (1982) Urinary excretion of carnitine and its derivatives in newborns. Biochem Med 27: 260–265Google Scholar
  14. 14.
    Cederblad G, Harper P, Lindgren K (1986) Spectrophotometry of carnitine in biological fluids and tissues with Cobas Bio centrifugal analyzer. Clin Chem 32: 342–346Google Scholar
  15. 15.
    Cederblad G, Floderus A, Karlsson KE (1976) A computer program for an open two compartment system distinguishing three models. Acta Physiol Scand 96: 471–477Google Scholar
  16. 16.
    Sjöqvist F, Borgå O, Orme ML'E (1986) Fundamentals of clinical pharmacology. In: Avery GS (ed) Drug treatment (3rd edn). ADIS Press, New ZealandGoogle Scholar
  17. 17.
    Cederblad G, Fåhraeus L, Lindgren K (1986) Plasma carnitine and renal-carnitine clearance during pregnancy. Am J Clin Nutr 44: 379–383Google Scholar
  18. 18.
    Borum PR (1983) Role of carnitine supplementation in clinical nutrition. In: Johnston IDA (ed) Advances in clinical nutrition. MTP Press Ltd, Lancaster Boston The HagueGoogle Scholar
  19. 19.
    Seim H, Schultze J, Strack E (1985) Catabolic pathways for high-dosed L(−)- or D(+)-carnitine in germ-free rats? Biol Chem Hoppe-Seyler 366: 1017–1021Google Scholar
  20. 20.
    Rebouche CJ, Mack DL, Edmonson PF (1984) L-Carnitine dissimilation in the gastrointestinal tract of the rat. Biochem 23: 6422–6426Google Scholar
  21. 21.
    Gudjonsson H, Li BUK, Shug AL, Olsen WA (1985) In vivo studies of intestinal carnitine absorption in rats. Gastroenterology 88: 1880–1887Google Scholar
  22. 22.
    Gudjonsson H, Li BUK, Shug AL, Olsen WA (1985) Studies of carnitine metabolism in relation to intestinal absorption. Am J Physiol 248: G313-G319Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • P. Harper
    • 1
  • C. -E. Elwin
    • 2
  • G. Cederblad
    • 1
  1. 1.Department of Clinical ChemistryDanderyd HospitalDanderydSweden
  2. 2.Department of Clinical Pharmacology, Karolinska InstituteDanderyd and Huddinge HospitalsHuddingeSweden

Personalised recommendations